Valeant Pharmaceuticals (VRX.TO) Buy, Sell or…

Home

Daily Stock Opinions and Ratings

Valeant Pharmaceuticals (VRX.TO)

0.00

-0.00 (0.00%)

39 watching

PAST TOP PICK

(Was a top pick on April 15. Down 51%) Still likes.

Wealthica Track your Stocks in your Watch List

BUY ON WEAKNESS

Would buy at $35/38.

BUY

Good range of products.

TOP PICK

Good price.

TOP PICK

Has grown their earnings 30% over the last four years. Good future guidance.

BUY

Had an excellent earnings report. At a good level.

BUY

Showing good numbers and at a good price.

DON'T BUY

Buy-back of shares has used their cash up. Risky at this time.

Wealthica Track your Stocks in your Watch List

DON'T BUY

Could drop further.

DON'T BUY

Pharmaceuticals/biotechs are under a lot of pressure. Doesn't see much growth for this year.

BUY

Biotechs have been hit. Profitable. Good product line. Good price.

TOP PICK

Good long term hold. At a low price. Multiple of about 15/18.

PAST TOP PICK

(Was a top pick on Mar 14. Down 56%) Still likes.

WEAK BUY

One of the better companies. Looking at it now.

BUY

Likes. Solid pipeline. Expects a bounce.

Showing 601 to 615 of 714 entries

Most Recent Experts

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Valeant Pharmaceuticals (VRX.TO)